SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-000543
Filing Date
2024-01-03
Accepted
2024-01-03 09:00:08
Documents
15
Period of Report
2024-01-02
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20240102.htm   iXBRL 8-K 52238
2 EX-3.1 sabs-ex3_1.htm EX-3.1 13121
3 EX-99.1 sabs-ex99_1.htm EX-99.1 14841
  Complete submission text file 0000950170-24-000543.txt   246163

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sabs-20240102_pre.xml EX-101.PRE 13161
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sabs-20240102.xsd EX-101.SCH 3214
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sabs-20240102_def.xml EX-101.DEF 13861
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sabs-20240102_lab.xml EX-101.LAB 17787
9 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20240102_htm.xml XML 6660
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 24504483
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)